98%
921
2 minutes
20
In the widespread use of medical cyclotrons for isotope production, radiological and economic consequences related to the decommissioning of particle accelerators are often neglected. However, decommissioning regulation and its related procedures always demand efforts and costs that can unexpectedly impact on budgets. The magnitude of this impact depends strongly on the residual radioactivity of the accelerator and of the vault, and more specifically on the kind and activity concentration of residual radionuclides. This work reports and discusses a case study that analyzes in detail the characterization activities needed for optimized management of the decommissioning of a medical cyclotron vault. In particular, this paper presents the activities carried out for assessing the activity concentrations and for guiding the disposal of the cyclotron vault of the Italian National Cancer Institute of Milano (INT). An unshielded 17 MeV cyclotron vault was characterized by high resolution gamma-ray spectrometry both in-situ and in-laboratory on extracted samples. Monte Carlo simulations were also carried out to assess the overall distribution of activation in the vault. After a few months from the final shutdown of the accelerator, activity concentrations in the concrete walls due to neutron activation exceeded the clearance levels in many regions, especially close to the cyclotron target. Due to the relatively long half-lives of some radionuclides, a time interval of about 20 y after the end of bombardment is necessary for achieving clearance in some critical positions. Far from the target or in positions shielded by the cyclotron, activation levels were below the clearance level. The comparison between Monte Carlo simulations and experimental results shows a good agreement. The in-situ measurements, simpler and economically advantageous, cannot completely replace the destructive measurements, but they may limit the number of required samples and consequently the decommissioning costs. The methodology described and the results obtained demonstrated that it is possible to obtain accurate estimations of activity concentrations with cheap and quick in-situ measurements if the concentration profile in-depth inside the wall is well known. This profile can be obtained either experimentally or numerically through suitably validated Monte Carlo simulations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/HP.0000000000001801 | DOI Listing |
Phys Med
August 2025
Medical Physics Department, Ospedale San Raffaele Via Olgettina 60, I-20132 Milano, Italy.
This study outlines the decommissioning process of an 11 MeV self-shielded medical cyclotron operated for over 12 years at the Ospedale San Raffaele, Milano, Italy. A comprehensive analysis of neutron-induced activation in the vault walls was performed to guide safe demolition procedures. Using FLUKA Monte Carlo simulations and laboratory-based gamma and beta spectrometry, the activity of long-lived radionuclides, particularly Fe, was evaluated across multiple wall depths.
View Article and Find Full Text PDFJ Radiol Prot
June 2024
Metaxa Cancer Hospital of Piraeus, 51 Mpotasi, Piraeus 185 37, Greece.
The role ofF-fluoro-deoxy-glucose in positron emission tomography (PET) imaging is well established in diagnosis and management of cancer patients. Installations of on-site self-shielded mini cyclotrons are increasing. The Dose on Demand Biomarker Generator BG-75 was installed at Metaxa Cancer Hospital, Greece, in May 2021 and is the first hospital-based PET radiopharmaceutical cyclotron in the country.
View Article and Find Full Text PDFHealth Phys
August 2024
Radiation protection unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milano, Italy.
In the widespread use of medical cyclotrons for isotope production, radiological and economic consequences related to the decommissioning of particle accelerators are often neglected. However, decommissioning regulation and its related procedures always demand efforts and costs that can unexpectedly impact on budgets. The magnitude of this impact depends strongly on the residual radioactivity of the accelerator and of the vault, and more specifically on the kind and activity concentration of residual radionuclides.
View Article and Find Full Text PDFPract Radiat Oncol
May 2024
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
Purpose: This work aims at reviewing challenges and pitfalls in proton facility design related to equipment upgrade or replacement. Proton therapy was initially developed at research institutions in the 1950s which ushered in the use of hospital-based machines in 1990s. We are approaching an era where older commercial machines are reaching the end of their life and require replacement.
View Article and Find Full Text PDFRadiat Prot Dosimetry
October 2023
Institute of Nuclear Engineering and Science, National Tsing Hua University, 101, Sec. 2, Kuang-Fu Road, Hsinchu 30013, Taiwan, R.O.C.
In sum, 11 (p,xn) related nuclear reactions with 9 target materials, namely 18O(p,n)18F, 15N(p,n)15O, 68Zn(p,n)68Ga, 68Zn(p,2n)67Ga, 69Ga(p,2n)68Ge, 89Y(p,n)89Zr, 100Mo(p,pn)99Mo, 100Mo(p,2n)99mTc, 112Cd(p,2n)111In, 124Xe(p,2n)123Cs and 203Tl(p,3n)201Pb, are involved in the operation of 13 radionuclide-production cyclotrons in Taiwan. The secondary neutrons accompanying these production routes could induce varying degrees of material activation in the cyclotron facility. Accordingly, this study compared the effects of various (p,xn) production routes on the neutron-induced long-lived radioactivity in the concrete walls of a hypothetical cyclotron vault.
View Article and Find Full Text PDF